Trial intelligence / Profile preview

Phase 2a study of AL-335 + odalasvir with or without simeprevir in treatment-naive chronic hepatitis C

2016-002845-46Phase 2Completed

Sponsor

Alios BioPharma

Start

Nov 2016

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1